Bandgap Modulation and Lipid Intercalation Generates Ultrabright D–A–D‐Based Zwitterionic Small‐Molecule Nanoagent for Precise NIR‐II Excitation Phototheranostic Applications

Pengfei Chen,Fan Qu,Shangyu Chen,Jiewei Li,Qingming Shen,Pengfei Sun,Quli Fan
DOI: https://doi.org/10.1002/adfm.202208463
IF: 19
2022-10-15
Advanced Functional Materials
Abstract:Via incorporating bandgap modulation and zwitterionic functionalization, the second near‐infrared (NIR‐II) excitation donor–acceptor–donor‐based small molecule with high QY (0.65%) and great photothermal property (η = 30.8%) is successfully developed, which can be intercalated within liposomes and retain its excellent optical properties in an aqueous environment, realizing precise in vivo 1064 nm single‐photon NIR‐II fluorescence imaging/photothermal therapy. Conjugated small‐molecule (CSM) phototheranostic agents that operate in the second near‐infrared (NIR‐II) region have garnered significant attention in the field of biomedicine. However, a lack of fluorescence‐emitting ability hinders their use in precise fluorescence imaging (FI)‐guided photothermal therapy (PTT). Herein, a two‐pronged fluorescence intensification strategy—molecular engineering for rational bandgap modulation and lipid‐intercalation to combat fluorescence quenching—is used to develop NIR‐II‐excited ultrabright donor–acceptor–donor‐based (D–A–D)‐based zwitterionic CSM nanoagent for tumor phototheranostics. The molecular engineering strategy produces the NIR‐II‐excited D–A–D‐based zwitterionic fluorophore (BTFQ) that exhibits a high NIR‐II fluorescence quantum yield (QY = 0.65%) in dichloromethane. More importantly, BTFQ complexed with liposome (DMPC) to form the zwitterion–liposome nanoagent (BTFQ/DMPC) shows a negligible loss of QY (0.63%) in aqueous media. Moreover, because BTFQ/DMPC possesses excellent photothermal conversion efficiency (PCE = 30.8%) performance, it can be used to realize efficient in vivo 1064 nm single‐photon high‐resolution NIR‐II FI guided NIR‐II PTT. This study introduces a new avenue for the development of NIR‐II‐excited NIR‐II FI/PTT agents for precise and effective tumor treatment.
materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology
What problem does this paper attempt to address?